Friday, October 23, 2015

08:30-10:00 
HALL A
Controversies in bone health  AMG Onc Blu
11:30-13:00 
HALL A
Controversies in HER2-positive disease
Roche 

Saturday, October 24, 2015

07:00-08:30 
HALL A
IORT for early breast cancer: From clinical trials to clinical reality  ZEISS
11:30-13:00 
HALL A
Management of endocrine resistance  Novartis